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ABSTRACT
Role of Protein Kinase C Isotypes in 1,25-dihydroxyvitamin D3 Mediated Signal
Transduction Through the 1,25D3 Membrane Associated, Rapid Response Steroid
Binding Receptors in Chick Intestinal Cells
by

Sakara Tunsophon, Doctor of Philosophy
Utah State University, 2010
Major Professor: Dr. Ilka Nemere
Department: Nutrition, Dietetics, and Food Sciences
It is now accepted that 1,25(OH)2D3 mediates its rapid actions on the control of
phosphate and calcium homeostasis through its membrane receptor termed the 1,25D3MARRS (membrane associated rapid response steroid binding) protein. I determined the
various PKC isotypes involved in the rapid regulation of phosphate uptake and calcium
extrusion in chick intestinal cells. 1,25(OH)2D3-mediated phosphate uptake was
stimulated within 1 min after addition of the hormone. Western blot analyses on isolated
intestinal cells treated with steroid hormone resulted in dose-dependent increases in
PKCα and PKCβ in postnuclear centrifugation fractions, but not in the low speed
centrifugation fractions. The highest immunoreactivity of PKCα was found after
treatment of the cells with 300 pM 1,25(OH)2D3 and declined at 650 pM hormone,
relative to corresponding controls, while the highest immunoreactivity of PKCβ was
found in cells treated with either 300 pM or 650 pM 1,25(OH)2D3. Therefore, PKCα and
PKCβ redistribution are likely to relate to the dose-response curve for both phosphate
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uptake and calcium efflux, respectively. Using transfection of primary cultures of
intestinal cells with siRNA for these two isotypes, I found decreased 32P uptake in cells
transfected with siRNA to either PKCα or PKCβ in both controls (relative to
untransfected controls), and hormone-treated cells. Further study of the effect of chemical
blockers for PKCα or PKCβ on phosphate uptake was conducted in suspensions of
isolated intestinal cells. The results from these experiments also confirmed the findings
from the siRNA experiments and demonstrated decreased 32P uptake in cells treated with
1,25(OH)2D3 plus blockers in comparison with cells treated with 1,25(OH)2D3 alone.
The effects of PKCα and PKCβ in steroid-mediated calcium extrusion were
further investigated using siRNA for PKCα or PKCβ. We found the siRNA to PKCβ
alone caused decreased calcium extrusion. We also found that the inhibitors of PKCβ, but
not PKCα, caused significantly enhanced calcium uptake by decreasing calcium efflux
from the cells. This result suggested that PKCβ might be involved in the rapid response
of 1,25(OH)2D3-stimulated calcium extrusion. I used confocal microscopy to study the
redistribution of PKCα and PKCβ in cells exposed to steroid hormone for 30 sec. PKCα
was found to increase significantly in the apical membrane after a 30 sec exposure of
cells to 300- or 650 pM 1,25(OH)2D3. By comparison, anti-PKCβ immunofluorescence
was found to increase significantly in the basal region of cells, relative to controls,
following exposure of cells to 300 pM seco-steroid. These combined results, lead me to
conclude the involvement of both PKCα and PKCβ in the signal transduction mechanism
of 1,25(OH)2D3-mediated phosphate uptake while PKCβ is involved in the mechanism of
1,25(OH)2D3-mediated calcium efflux in chick intestinal epithelial cells.
(95 pages)
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CHAPTER 1
INTRODUCTION

Vitamin D
Vitamin D is biologically inactive, and it must be metabolized to its biologically
active forms. Vitamin D is normally produced in the skin or taken up by the diet. During
exposure to sunlight, 7-dehydrocholesterol (7-DHC) in the skin absorbs UV light to
produce previtamin D3 and later vitamin D3. The vitamin D3 enters the blood circulation
by binding with vitamin D binding protein, and is transported to the liver where it is
metabolized to 25-hydroxyvitamin D3 [25(OH)D3] by an enzyme in the liver called
vitamin D-25-hydroxylase (25-OHase). The 25-hydroxyvitamin D3 then goes to the
kidney and is hydroxylated to form two active metabolites 1) 24,25-dihydroxyvitamin D3
[24,25(OH)2D3] by 25-hydroxyvitamin D3-24-hydroxylase (24-OHase), and 2) 1,25dihydroxyvitamin D3 [1,25(OH)2D3]-the most potent stimulatory form of vitamin D-by
25-hydroxyvitamin D3-1a-hydroxylase (1-OHase). Most of the physiological effects of
vitamin D in the body are related to the activity of this metabolite (Holick 2003, 2004;
Sutton and McDonald, 2003; DeLuca, 2004). However, there is also evidence showing
that 24,25(OH)2D3 has physiological functions such as its effects on bone metabolism
(Dean et al., 2001; van Leeuwen et al., 2001) and its role to suppress the rapid action of
1,25(OH)2D3 in kidney (Khanal et al., 2007) and intestine (Nemere et al., 2006; Larsson
et al., 2006).
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the steroid hormone which is well
known for its functions to regulate phosphate and calcium homeostasis in many organs,
especially in intestine, kidney and bone. In addition to the control of mineral balance,
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Fig. 1.1 Structure of vitamin D and its metabolites
1,25(OH)2D3 is involved in many physiological responses such as cell proliferation and
differentiation, immune modulation, control of blood pressure and insulin secretion
(Christakos et al., 2003; Dusso et al., 2005; Norman, 2008).
Mechanism of action
The effect of 1,25(OH)2D3 are mediated through two mechanisms.
1. Genomic actions - The cellular actions of this hormone are due to the binding
of the hormone to a nuclear vitamin D receptor (nVDR), and represents a slow
mechanism since it is involved with gene transcription and protein synthesis, for example
in bone matrix (Christakos et al., 2003). This ligand-receptor complex interacts with the
retinoid X receptor, and regulates the expression of approximately 500 genes (Norman,
2008).
2. Pregenomic or rapid response actions - There are some cellular responses that
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are rapidly stimulated by 1,25(OH)2D3 and cannot be explained by the slow mechanism
via nVDR. This action is mediated through the 1,25D3-MARRS receptor. The signal
transduction pathway involved in the rapid stimulation of mineral transport can be
activated through protein kinase C (PKC), phospholipase C (PLC), protein kinase A
(PKA) and mitogen activated protein (MAP) kinase (de Boland and Norman, 1998;
Farach-Carson and Nemere, 2003; Fleet, 2004; Norman et al., 2004).
Phosphate homeostasis
The regulation of phosphate homeostasis in the body is maintained primarily by
intestinal absorption, renal excretion, and subsequently by bone remodeling under the
control of parathyroid hormone (PTH), 1,25(OH)2D3, 24,25(OH)2D3 (Nemere, 1996a,b;
Carpenter et al., 1996; Khanal et al., 2007) and phosphatonins (Berndt and Kumar, 2007).
Phosphate is required by every cell for normal physiological functions and metabolic
reactions such as energy metabolism, nucleic acid synthesis, bone mineralization,
membrane function and cell signaling (Berndt et al., 2005).
Phosphate is abundant in the diet, and normally absorbed efficiently by the
intestine. However, a prolonged period of taking excess amounts of phosphate is believed
to result in bone impairment and aging (Takeda et al., 2004). Therefore control of the
balance between phosphate input and output is important. Plasma phosphate homeostasis
is maintained by absorptive and secretory fluxes in kidney, bone and intestine and
sometimes muscle. Under physiological circumstances, the intestine plays a major role in
regulation of phosphate. However, under normal events, the kidney plays a role in
maintaining phosphate homeostasis. Along the different segments of small intestine,
phosphate is normally taken up by passive paracellular transport along a concentration
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gradient. Active transcellular transport occurs along the intestine as well but against an
electrochemical gradient. Transcellular transport of phosphate across the enterocytes
involves at least three steps
1) transport across the brush border membrane via a mechanism consisting of
Na+/Pi cotransporters, or the more recently discovered Npt2b transporter (Sabbagh et al,
2009), and by PKC mediated signal transduction (Zhao and Nemere, 2005)
2) transport through the cytoplasm most likely occurs in vesicles (Nemere,
1996b), and
3) transport across the basolateral membrane by a Na+ independent carrier
mediated mechanism (Radanovic et al., 2005; Berndt and Kumar, 2007), and vesicular
exocytosis.
In normal phosphate status, the amount of intestinal phosphate absorption is equal
to the amount of renal phosphate excretion. Low serum phosphate induces the stimulation
of 1α-hydroxylase in the kidney, subsequently increasing 1,25(OH)2D3 synthesis. The
increased 1,25(OH)2D3, along with PTH results in increased intestinal absorption of
phosphate in the small intestine of young, growing animals (Nemere et al., 2004).
Additionally, 1,25(OH)2D3 increases renal reabsorption of phosphate in kidney and
stimulates bone mobilization to release phosphate into the serum. Thus, these
mechanisms are important to maintain normal phosphate in blood circulation. The
opposite mechanisms will take place when phosphate in the circulation is high (Nemere
and Larsson, 2002; Berdnt and Kumar, 2007; Nemere, 2007; Peery and Nemere, 2007).
Calcium homeostasis
One of the most abundant elements in the body is calcium. Approximately 99% of
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calcium is found in bones and teeth. The remainder is found in body fluids such as blood
and cells of other tissues. Calcium is a crucial element that plays an essential role in
several physiological and biochemical processes. It is needed for skeletal and smooth
muscle contraction, blood coagulation, neuromuscular excitability, nerve impulse
transmission, cell permeability, cell adhesion, hormone and enzyme secretion,
stabilization and activation of proteins and enzymes. Calcium concentrations in the blood
and extracellular fluid need to be maintained in order to preserve the normal
physiological functions (Wasserman, 2005; Collins and Ghishan, 2006; Forsell et al.,
2006; Khanal and Nemere, 2008).
One of the major organs to regulate calcium homeostasis is the small intestine.
Transcellular calcium transport across the intestine is a three step process (Bouillon et al.,
2003).
1) entry at the brush border membrane by a Ca2+ channel called TRPV6, or a
calcium carrier such as H+/Ca2+ exchanger (Wasserman, 2005; Collins and Ghishan;
2006). TRPV6 delivery to the membrane is mediated by PKA (Khanal et al., 2008)
2) transcellular movement by a vesicular transport mechanism in which the Ca2+
and calbindin enriched vesicles are transported vectorially along microtubules (Nemere et
al., 1991; Sterling and Nemere, 2005; Khanal and Nemere, 2008; Khanal et al., 2008)
mediated by PKA signal transduction. Another mechanism may be by tunneling through
intracellular stores.
3) Extrusion at the basolateral membrane by Na+-Ca2+ exchanger and Ca2+
ATPase or by PKC-mediated vesicular exocytosis (Nemere and Campbell, 2000; Khanal
and Nemere, 2008).
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In addition to the indicated actions on kidney and bone, PTH acts directly on
intestine to increase calcium absorption (Khanal and Nemere, 2008). Calcium-sensing
proteins in the parathyroid glands monitor serum calcium levels. In the event of a slight
decrease in serum calcium, the parathyroid glands secrete PTH). PTH stimulates an
enzyme in the kidney which is called 1α-hydroxylase, resulting in an increased
production of 1,25(OH)2D3 (calcitriol), an active metabolite form of vitamin D.
1,25(OH)2D3 and PTH activate the calcium transporter in the brush border membrane
(BBM) of small intestine (Khanal et al., 2008), increasing absorption of calcium. Both
1,25(OH)2D3 and PTH act on bone by increasing bone resorption (release) to increase the
calcium concentration into the circulation. In the kidneys, 1,25(OH)2D3 and PTH increase
calcium reabsorption. If the circulating calcium is high, the regulation will be in the
opposite direction (Nemere, 2005; Perez et al., 2008; Khanal and Nemere, 2008).
Protein Kinase C
PKC is a family of phospholipid-dependent serine-threonine kinases consisting of
at least 10 known isoforms. It is a key enzyme involved in signal transduction in many
cellular pathways such as cell proliferation and differentiation, membrane trafficking,
cytoskeleton organization and modulation of ion transport. The isozymes are divided into
three subgroups, based on their substrate specificity, Ca2+ and cofactor requirements:
conventional (or classical), novel, and atypical isoforms (Farhadi et al., 2006).
Conventional PKCs (cPKCs) consist of the PKCα, PKCβ, and PKCγ isoforms. The
activation of this group requires Ca2+, diacylglycerol (DAG) (or phorbol ester), and
phospholipids such as phosphatidylserine or phosphatidylcholine (Orsenigo et al., 2002).
The novel (nPKCs) isoforms (PKCδ, PKCε, PKCη, and PKCθ) require DAG, but not
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Fig. 1.2 Regulation of PTH and 1,25(OH)2D3 in calcium homeostasis
Ca2+ for activation. The atypical (aPKCs) including PKCζ and PKCι/λ isoforms do not
require Ca2+ or DAG for activation. Thus, cPKCs are Ca2+ dependent whereas nPKCs and
aPKCs can be activated in a Ca2+ independent pathway (Parker and Murray-Rust, 2004).
PKC isoforms are distributed in various tissue and cell specific patterns and also
exhibit differences in subcellular localization within cell types (Newton, 2001; Song et
al., 2001). PKC activation is determined by measuring the intracellular translocation of
an isoform to a membrane or cytoskeleton. We can measure protein redistribution after
subcellular fractionation by western blotting or by immunostaining of intact cells
(Dempsey et al., 2000).
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Fig. 1.3 Domain Structure of Protein Kinase C
Statement of Problems
The effects of 1,25(OH)2D3 are mediated in part through slower transcriptional
mechanisms over a period of hours and are initiated by the nuclear vitamin D receptor
(VDR), and possibly the 1,25D3-MARRS receptor (Nemere et al., 2000; Rohe et al.,
2007), as well as by rapid responses occurring within seconds to minutes, mediated
through membrane-initiated signal transduction pathways (Farach-Carson and Nemere,
2003).
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Balogh et al. (2000) have shown an altered subcellular distribution of specific
PKC isozymes after short incubations with 1,25(OH)2D3 in rat duodenum, and that
hormone regulated enzyme modulation and redistribution were impaired with aging.
Phosphate uptake
Previous studies (Zhao and Nemere, 2002; Nemere et al., 2004) have
demonstrated that intestinal cells from chicks can be rapidly stimulated to take up
phosphate through a signal transduction pathway mediated by protein kinase C (PKC).
This mechanism can be activated via the 1,25D3-MARRS receptor, which is identical to
PDIA3 (Nemere et al., 2004). The studies also showed decreasing phosphate uptake with
increasing age which was correlated with decreasing PKC activity.
In rat, membrane initiated signaling relies on both cell surface VDR and the
1,25D3-MARRS receptor, whereas in chick intestinal cells, only the 1,25D3-MARRS
receptor is required (Nemere, 2005). Studies with ribozymes in chick intestinal cells have
demonstrated that the 1,25D3-MARRS receptor is responsible for steroid hormonestimulated phosphate uptake and activation of PKC (Nemere et al., 2004).
Calcium extrusion
In the facilitated diffusion model of calcium transport, calcium extrusion at the
basolateral membrane (BLM) is mediated by an ATP-dependent Ca2+ pump and Na+-Ca2+
exchanger (Wasserman et al., 1992; Khanal et al., 2008). The purpose of this mechanism
is to prevent the accumulation of divalent cation which is toxic to the cells. While we
have identified the PKA signaling pathway as the likely mediator of calcium uptake in
intestinal cells (Phadnis and Nemere, 2003; Sterling and Nemere, 2007), PKC signaling
has been identified in calcium extrusion (Nemere and Campbell, 2000) possibly by
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facilitating exocytosis of vesicular transport calcium. Similarly, the study of Farhadi et al.
(2006) indicated that PKC normalized intracellular calcium by modulating calcium
efflux.
Ca2+ dependent protein kinases are known to regulate the activity of several
membrane bound ion channels and carriers in various tissues, thereby modulating
transmembrane ion transport (Halet et al., 2004). In small intestine, various kinds of PKC
isoforms have been identified at the mRNA or protein level, including cPKCs (Farhadi et
al., 2006).
Up to now, data concerning the effect of PKC activation on phosphate (Zhao and
Nemere, 2002; Nemere et al., 2004) and calcium transport (Balogh et al., 1997; Larrson
and Nemere, 2003) in the small intestine have been incomplete. The purpose of this study
was to examine which Ca2+ dependent PKCs modulate the transport systems involved in
steroid-mediated phosphate uptake and calcium extrusion, in order to provide a more
detailed understanding of how intracellular signaling mechanisms regulate the transport
of ions.
Specific Aims
The specific aims of the proposed research are to:
1.) Identify the cPKCs involved in 1,25(OH)2D3 stimulated rapid phosphate
uptake
2. ) Identify the cPKCs involved in 1,25(OH)2D3 stimulated calcium extrusion
Part I – Protein Kinase C isotypes in signal transduction for the 1,25D3-MARRS
receptor (ERp57/PDIA3) in steroid hormone-stimulated phosphate uptake
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Hypothesis
“cPKCs are involved in the mechanism of signal transduction of 1,25D3-stimulated
phosphate uptake”
Objectives
1.) To determine the conventional protein kinase C (cPKC) redistribution in
response to 1,25(OH)2D3 in isolated intestinal cells
2.) To identify the role of cPKCs in 1,25(OH)2D3 mediated phosphate uptake in
cultured intestinal epithelial cells using siRNA to PKC specific isotypes
3.) To evaluate cPKCs in 1,25(OH)2D3 mediated phosphate uptake in isolated
intestinal cells using PKC chemical blockers to specific isotypes
Part II – Protein Kinase C isotypes in signal transduction for the 1,25D3-MARRS
receptor (ERp57/PDIA3) in steroid hormone-stimulated calcium extrusion
Hypothesis
“cPKCs are involved in the mechanism of signal transduction of 1,25D3-stimulated
calcium extrusion”
Objectives
1.) To determine the role of PKCα and β in 1,25(OH)2D3 mediated calcium
extrusion in cultured intestinal epithelial cells using siRNA to specific PKC isoforms
2.) To evaluate the role of PKCα and β in 1,25(OH)2D3 mediated calcium
extrusion in isolated intestinal cells using PKC chemical blockers to specific isoforms
3.) To evaluate PKCα and β redistribution pattern in response to 1,25(OH)2D3 by
using confocal microscopy.
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CHAPTER 2
PROTEIN KINASE C ISOTYPES IN SIGNAL TRANSDUCTION FOR THE 1,25D3MARRS RECEPTOR (ERp57/PDIA3) IN STEROID HORMONE-STIMULATED
PHOSPHATE UPTAKE1

Abstract
I undertook studies to determine which isotype(s) of protein kinase C (PKC) is/are
activated by ligand binding to the 1,25D3-MARRS receptor (ERp57/PDIA3) and
subsequent stimulation of phosphate uptake. Isolated intestinal epithelial cells were
exposed to 1,25(OH)2D3 for 1, 3, or 5 min, thoroughly chilled, homogenized, and P2
fractions (20,000 x g post-nuclear pellet) prepared. Western analyses with anti-pan PKC
revealed steroid-stimulated redistribution to P2 membranes 1 min after hormone. Using
this time point, cells were treated with vehicle control, 130 pM-, 300 pM- or 650 pMhormone. Western blots with anti-PKCα exhibited redistribution to membranes in a
biphasic dose-response curve: slightly stimulated at the lowest dose, maximal at 300 pM
1,25(OH)2D3, and equivalent to control levels at the highest dose, paralleling hormonemediated phosphate uptake. Westerns with anti-PKCβ also revealed hormone-mediated
differences, while those with anti-PKCγ did not. RNAi studies were then performed with
siRNA against PKCα or PKCβ. Untransfected cells treated with hormone for 7 min
exhibited enhanced 32P uptake relative to vehicle controls. Cells transfected with either
active siRNA revealed decreased 32P uptake in both controls (relative to untransfected
controls), and hormone treated cells. However, control and treated transfected cells had
equivalent levels of uptake. Western blot analyses confirmed decreased immunoreactivity
1
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in transfected cells. PKCα and PKCβ blockers also confirmed the results from siRNA
and demonstrated decreased 32P uptake in cells treated with 1,25(OH)2D3 plus blockers in
comparison with cells treated with 1,25(OH)2D3 alone.
Introduction
The regulation of phosphate in the body is maintained by intestinal absorption,
renal excretion, and bone remodeling under the control of parathyroid hormone (PTH),
1,25- dihydroxyvitamin D3 [1,25(OH)2D3], and 24,25-dihydroxyvitamin D3
[24,25(OH)2D3] [1,2]. Phosphate is required for normal cellular functions and
physiological processes such as energy metabolism, nucleic acid synthesis, bone
mineralization, and cell signaling [3]. The effects of 1,25(OH)2D3 are mediated through
slower transcriptional effects over a period of hours initiated by the nuclear vitamin D
receptor (VDR), and possibly the 1,25D3-MARRS receptor [4,5] and by rapid responses
occurring within seconds to minutes, mediated through membrane-initiated signal
transduction pathways [6].
We have demonstrated in previous studies that 1,25(OH)2D3 mediated phosphate
uptake in isolated chick intestinal cells exactly parallels the observations in perfused
duodenal loops [7], indicating uptake is across the brush border. We have also found that
1,25(OH)2D3 mediated phosphate uptake decreases with increasing age and is correlated
with decreasing protein kinase C (PKC) activity [7,8]. PKCs are a family of
phospholipid-dependent serine-threonine kinases. It is a key enzyme in regulation of cell
growth and differentiation and modulation of ion transport. Balogh et al. [9] have shown
the altered subcellular distribution of specific PKC isozymes after short incubations with
1,25(OH)2D3 in rat duodenum, and that hormone regulated enzyme modulation and
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redistribution were impaired with aging.
In rat, membrane initiated signaling relies on both cell surface VDR and the
1,25D3-MARRS receptor, whereas in chick intestinal cells, only the 1,25D3-MARRS
receptor is required [10]. Studies with ribozymes in chick intestinal cells have
demonstrated that the 1,25D3-MARRS receptor is responsible for steroid hormonestimulated phosphate uptake and activation of PKC [8]. In the present study we test the
involvement of several isozymes in steroid-mediated phosphate uptake. While others [1113] have catalogued isoforms activated by 1,25(OH)2D3 activity, we are the first to relate
specific isotypes to the physiological endpoint of phosphate uptake.
Material and Methods
Animal and Surgical Methods
All protocols were approved by the Institutional Animal Care and Use Committee
at Utah State University (Logan, UT). White leghorn cockerels (Privett Hatchery;
Portales, NM) were obtained on the day of hatch and raised for 3-7 wks on a vitamin Dreplete diet (Nutrena Feeds; Murray, UT). On the day of the experiments, chicks were
anesthetized with chloropent (0.3 ml/100 g body weight), the duodenal loop was removed
to ice-cold 0.9% saline and chilled for 15 min. The pancreas was excised and the
duodenal loop was everted and rinsed three times with ice-cold saline.
Cell Isolation
The intestinal epithelial cells were isolated as previously described [8,14]. The
everted duodenal loop was gently stirred for 15 min at 23oC in citrate chelation solution
containing 96 mM NaCl, 27 mM NaCitrate.2H2O, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM
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Na2HPO4, pH 5.0. The intestinal segment was then transferred to fresh solution and cells
released in the previous incubation transferred to 50-ml conical centrifuge tubes. The
isolation protocol was repeated two more times. The cells were collected by low speed
centrifugation (500 x g, 5 min, 4oC). Cell pellets were resuspended in Gey’s Balanced
Salt Solution (GBSS, 119 mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM
NaHPO4, 1.03 mM MgCl2.6H2O, 0.28 mM MgSO4.7H2O, 0.9 mM CaCl2, pH 7.4). To
minimize clumping, the cells were gently spread along the walls of the centrifuge tube
with a Teflon rod at room-temperature, and GBSS added drop-wise, with stirring, until a
suspension was formed.
Time Course and Dose-Response Studies
Six ml of cell suspension was pipetted into each of six conical centrifuge tubes
and incubated with vehicle (0.012% ethanol, final concentration) or 300 pM 1,25(OH)2D3
for 1, 3, or 5 min (time course study, 23oC). Cells were then thoroughly chilled on ice for
10 min prior to collection by centrifugation (500 x g, 5 min, 4oC). The pellets were
homogenized with 20 strokes in 8 ml of homogenization medium containing 250 mM
sucrose, 5 mM histidine-imidazole, 2 mM EGTA, pH 7.0 [15] and centrifuged at 1000 x
g, 20 min, 4oC. The pellets (P1) were resuspended in 4 ml of homogenization medium and
stored frozen until further use. The post-nuclear supernatant fractions were centrifuged at
20000 x g, 10 min, 4oC to yield pellet fractions (P2), which were resuspended in 200 µl
of homogenization medium and also frozen until used for Western analyses as described
below. P1 pellets contain nuclei, brush borders and large cell debris. P2 pellets contain
basal lateral membranes, Golgi, mitochondria, lysosomes and peroxisomes [16].
For dose response studies, similar procedures were used except incubation of the cells
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occurred with vehicle or 130, 300 and 650 pM of 1,25(OH)2D3 hormone for 1 min.
Cell Culture
For studies with siRNA against PKCα or PKCβ (Ambion, Austin, TX), cells were
resuspended in 40 ml of GBSS and aliquots (0.2 ml) pipetted into 35 mm plastic Petri
dishes (Falcon, Fisher Scientific; Franklin Lakes, NJ) with 3 ml of RPMI-1640 medium
(Hyclone, Logan, UT), and antibiotics containing 100 units/ml of penicillin and 100
µg/ml of streptomycin (Sigma Chemical Co; St. Louis, MO). The cells were incubated
overnight at 37oC, 5% CO2/95% air without serum to promote cell adherence. The
following day, medium was aspirated and the cells were transfected with SiImporter
(Millipore, Bedford, MA) as described by the manufacturer’s product protocol (Upstate,
Lake Placid, NY, 2005) with 100 nM siRNA, final concentration (Ambion, Austin, TX).
Briefly, for each plate 930 µl of RPMI-1640 medium was combined with 65 µl of a
solution containing 5 µl of SiImporter, 25 µl of siRNA diluent, 35 µl of RPMI-1640 and
5 µl of siRNA (transfected cells) or scrambled RNA (Santa Cruz Biotechnology, Santa
Cruz, CA) or without siRNA (mock transfected cells), mixed gently and incubated at
room temperature for 5 min. The transfection mixture was then added to the cultured
cells and incubated for 4 hrs. After the incubation period, 3 ml of RPMI-1640 with 10%
FBS and antibiotics were added to each Petri dishes (Falcon Scientific Products; Franklin
Lakes, NJ). Incubation was continued for 24 hrs at 37oC, 5% CO2/95% air and the
cultures were assayed for phosphate uptake as described below.
Phosphate Uptake
After 48 hours of incubation, the medium was aspirated and replaced with 1 ml of
GBSS containing 0.1% BSA (23oC). At T = 0, an equal volume of buffer was added
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containing radioactivity (2 µCi of H332PO4 [Perkin Elmer Life Sciences, Boston, MA] per
ml, final concentration) and either vehicle (0.012% ethanol, final concentration) or 300
pM 1,25(OH)2D3 (final concentration), and the incubation continued for 7 min—a time
found earlier to be optimal for observing hormone-mediated differences in uptake [17].
Media were then aspirated and the cells were rinsed with 4 ml of ice-cold GBSS three
times, followed by the addition of 0.5 ml of lysis buffer (0.1% (v/v) triton X-100 in TED
containing 10 mM Tris, 1.25 mM EDTA, 2mM dithiothreitol, pH 7.4). Cells were
scraped, solubilized and collected for determination of radioactivity by liquid scintillation
spectrophotometry and protein. The remaining samples were frozen for Western analyses.
SDS-PAGE and Western Analyses
Protein samples were separated on 8% (w/v) SDS-polyacrylamide gel with a 5%
stacking gel. After separation on SDS-PAGE, proteins were transferred to polyvinylidene
difluoride (PVDF) membranes (Immobilon-P, Fisher Scientific, Dallas, TX) by using a
Trans-Blot SD semidry transfer cell (Bio-Rad Laboratories, Inc., Hercules, CA) at 15 V
for 1 h. The membrane was soaked in blocking solution containing 0.5% nonfat dry milk
in phosphate buffered saline (PBS) for 1 h at 37oC to prevent non specific binding. The
membrane was then washed three times, 5 min each, with wash buffer containing 0.1%
(w/v) BSA in Tris-buffered saline (TBS; 0.02% NaN3 and 0.9% NaCl in 20 mM TrisHCl, pH 7.4), followed by incubation overnight at 4oC with primary antibody: either the
anti-pan PKC (1/500, Zymed, San Francisco, CA), anti-PKCα (1/20000, Sigma-Aldrich),
anti-PKCβ (1/500, Zymed) or anti-PKCγ (1/1000, Zymed) in antibody incubation
solution (1 % BSA and 0.05% TWEEN-20 in TBS). In addition, we incubated
membranes as well with Ab593 (1/500) which is an antibody against 1,25D3-MARRS
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receptor (generated by the multi-antigenic peptide technique) and used as a loading
control. The following day, the membrane was washed three times and incubated with
alkaline phosphatase-conjugated secondary antibody for 1 h at room temperature
(1/5000-10000 as specified by instructions in the ECF kit (Amersham Biosciences,
Piscataway, NJ), followed by three additional washes. After that, the PVDF membrane
was incubated with ECF substrate for 30 min. Bands were visualized with the ECF
substrate using a Kodak Image Station 2000R. Band intensity from Westerns were
quantified by pixel intensity using Adobe Photoshop CS2.
Cell Suspension
Chicken intestinal cells were isolated by citrate chelation as described above and
were resuspended in room temperature Gey’s Balanced Salt Solution (GBSS; 23oC)
containing 0.1% BSA. Fourteen milliliters of cell suspension was pipetted into a
polypropylene tube which contained 2 μCi/ml of H332PO4 or 1 μCi/ml of 45CaCl2, final
concentration (Perkin Elmer Life Sciences, Boston, MA), at T = -10 min. Aliquots (3.2
ml) of cell suspension were pipetted into four fresh tubes and samples (100 μl) were
removed at T = -5 and -1 min to establish basal uptake. At T = 0 min, the cells were
treated with the vehicle ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to
produce the following incubation conditions: (1) controls (2) 300 pM 1,25(OH)2D3 (3)
control plus PKCα blocker (4) 300 pM 1,25(OH)2D3 plus PKCα blocker. Another series
of experiments were done with the same procedures to produce the following conditions:
(1) controls (2) 300 pM 1,25(OH)2D3 (3) control plus PKCβ blocker (4) 300 pM
1,25(OH)2D3 plus PKCβ blocker.
At T = 1, 3, 5, 7, and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS
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to stop uptake. Cell samples were placed on ice and centrifuged (1,000 x g, 5 min, 4oC) at
the end of the time course. The supernatants were decanted and the tubes were swabbed
with a Kimwipe while still in the inverted position. The pellets were resuspended in 500
μl of double-distilled water. The aliquots (100 μl) were pipetted into 3 ml of liquid
scintillation cocktail for the determination of radioactivity and 20 µl of aliquots were
taken to determine protein by the Bradford reagent. Specific radioactivity (cpm/μg
protein) was calculated and then values obtained for the treated phase were normalized to
average basal phase.
Protein Determination
The protein concentration was determined using Bradford reagent (BioRad) and
bovine γ-globulin as the protein standard.
Statistical Analysis
All values were expressed as mean + SEM. Statistical comparisons between two
treatment groups were compared by one way ANOVA (SigmaStat 3.1 and SigmaPlot
9.0). Significant differences were considered to occur at P < 0.05.
Results
Time course of 1,25(OH)2D3-mediated redistribution
of protein kinase C in isolated intestinal epithelial cells
Time course studies were undertaken by incubating cell suspensions with vehicle
(0.012% ethanol, final concentration) or 300 pM 1,25(OH)2D3 for 1, 3, or 5 min,
followed by thorough chilling prior to centrifugation. Cell pellets were homogenized,
and P1 and P2 fractions prepared. Western analyses of P1 fractions with an anti-pan PKC
primary antibody failed to detect any hormone-mediated redistribution of PKC
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immunoreactivity (data not shown) under the present conditions. By comparison, P2
fractions did exhibit hormone- and time-dependent redistribution of immunoreactivity. A
representative immunoblot (n = 3) is presented in Fig. 1A. The highest level of
immunoreactivity occurred in cells treated with 1,25(OH)2D3 for 1 min (Fig 2.1A).
Figure 2.1B presents the results of 3 independent experiments expressed as a ratio of
immunoreactive fluorescence in samples prepared from 1,25(OH)2D3 treated cells
relative to corresponding control values. The ratios for 1, 3, and 5 min of incubation
were 1.397 + 0.087, 1.245 + 0.042 and 1.092 + 0.026, respectively. Thus, 1,25(OH)2D3
treatment for 1 min resulted in an 40% increase in PKC associated with P2 membranes (P
< 0.01, relative to controls). The 1 min time point was subsequently chosen for dose
response studies using PKC-isotype specific antibodies.

Dose-response studies with isotype-specific antibodies
The dose response studies were performed with procedures equivalent to those
used in the time course studies. Cells were incubated with vehicle or 130 pM, 300 pM or
650 pM 1,25(OH)2D3 for 1 min (n = 3), thoroughly chilled, and then homogenized for
preparation of P2 fractions. A representative Western using anti PKCα and Ab593 as
primary antibodies are shown in Fig 2.2A. Cells treated with 300 pM 1,25(OH)2D3 were
found to have the highest immunoreactivity in subsequently prepared P2 fractions.
Quantitation of the results for 3 experiments are presented in Fig 2.2B in which a ratio of
fluorescence intensity in samples from steroid treated cells are related to control values.
Both are normalized to the band intensities of the 1,25D3-MARRS-binding protein. The
ratios were 1.218 + 0.078, 1.540 + 0.048 (**P < 0.1) and 1.140 + 0.052, relative to other
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Fig. 2.1 (A) Western analysis with anti-pan-PKC. Enterocytes were isolated with citrate
chelation and collected by centrifugation at 500 x g for 5 min, 4oC. Cell pellets were
resuspended in GBSS, and 6 ml of suspension incubated with vehicle or 300 pM of
1,25(OH)2D3 for 1, 3, or 5 min. Cells were then thoroughly chilled on ice prior to
collection by centrifugation. Cell pellets were homogenized in homogenization medium
and P2 fractions prepared. Aliquots of P2 pellets (25-50 µg) were separated on 8% (w/v)
SDS-polyacrylamide gel with 5% stacking gel and transferred to PVDF. Cells were
incubated by using the anti-pan PKC and Ab593 as primary antibodies followed by
alkaline phosphatase conjugated secondary antibody. Bands were visualized with the
ECF substrate using a Kodak Imager. Upper bands are Pan PKC and lower bands are the
1,25D3-MARRS receptor. Lanes 1, 3 and 5 were controls at 1, 3, and 5 min, respectively
(1C, 3C and 5C), lanes 2, 4, and 6 were cells incubated with 1,25(OH)2D3 for 1, 3, and 5
min, respectively (1D, 3D and 5D).
Fig. 2.1 (B) After subtracting background, the mean intensity of the anti-pan-PKC bands
were calculated as a ratio of 1,25(OH)2D3 treatment at 1, 3, and 5 min, relative to
corresponding control values. Data are represented as mean + S.E.M. for three
independent experiments (*P value < 0.05 and **P value < 0.01, relative to the ratio at 5
min).
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concentrations for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively. These
results—a biphasic dose-response curve with optimum at 300 pM steroid hormone—
closely parallel 1,25(OH)2D3-stimulated phosphate uptake [9].
Western analyses with anti PKCβ (Fig. 2.3A) and anti PKCγ (Fig 2.4A) were also
performed. Increased anti PKCβ immunoreactivity in P2 fractions of hormone-treated
intestinal epithelial cells was observed after 130-, 300-, and 650 pM steroid (Fig. 2.3A).
Quantitations of the results for 3 experiments is presented in Fig 2.3B in which a ratio of
fluorescence intensity in samples from steroid treated cells are related to control values.
The ratios were 1.041 + 0.045, 1.461 + 0.134 (**P value < 0.01) and 1.520 + 0.091 (**P
value < 0.01), for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively. While
these data most closely parallel 1,25(OH)2D3-stimulated calcium uptake, they also
indicate PKCβ may be involved in steroid-stimulated phosphate uptake.
Equivalent experiments with anti-PKCγ as primary antibody indicated there was
no effect of 1,25(OH)2D3 on redistribution of immunoreactivity (Fig. 2.4A). Quantitation
of the results for 3 experiments is presented in Fig 4B in which a ratio of fluorescence
intensity in samples from steroid treated cells are related to control values. There were no
significant differences among treatment groups. The ratios were 1.075 + 0.0.078, 0.966 +
0.072 and 1.055 + 0.059, for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively.
Effect of siRNA against PKCα or PKC β on
phosphate uptake in cultured intestinal cells
The results of the dose response studies suggested that either PKCα and/or PKCβ
is/are the isotypes most likely mediating 1,25(OH)2D3-stimulated phosphate uptake in
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Fig. 2.2 (A) Western analysis with anti-PKCα. Isolated cells were prepared as described
in the legend to Fig 2.1 and incubated for 1 min with vehicle or a range of hormone
concentrations. P2 fractions were prepared for Western analysis using anti-PKCα and
Ab593 as primary antibodies. Upper bands are PKCα and lower bands are the 1,25D3‐
MARRS receptor. Lane 1 was control (CON), lanes 2, 3 and 4 were fractions from cells
incubated with 130-, 300-, or 650 pM 1,25(OH)2D3, respectively (130, 300, or 650).
(B) Band intensity of anti-PKCα. Data were calculated as described in the legend to Fig.
2.1 for three independent experiments (**P value < 0.01, relative to intensity ratios
calculated for cells incubated with 130-, or 650 pM 1,25(OH)2D3).
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Fig. 2.3 (A) Western analysis with anti-PKCβ. Procedures were as described in the legend

to Fig 2.2, and Westerns performed using anti-PKCβ and Ab593 as primary antibodies.
Upper bands are PKCβ and lower bands are the 1,25D3‐MARRSreceptor. Lane 1, control
(CON), lanes 2, 3 and 4 were fractions from cells incubated with 130-, 300-, or 650 pM
1,25(OH)2D3, respectively (130, 300 and 650).
(B) Band Intensity of anti-PKCβ. Data were calculated as described in the legend to Fig.
2.1 for three independent experiments (**P value < 0.01, relative to cells incubated with
130 pM 1,25(OH)2D3).
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Figure 2.4 (A) Western analysis with anti-PKCγ. Procedures were as described in Fig
2.2, and Westerns performed using anti-PKC γ and Ab593 as primary antibodies. Upper
bands are PKCγ and lower bands are the 1,25D3‐MARRS receptor. Lane 1, control
(CON), lanes 2, 3, and 4 were fractions from cells incubated with 130-, 300-, or 650 pM
1,25(OH)2D3, respectively (130, 300 and 650).
(B) Band intensity of anti-PKCγ. Data were calculated as described in the legend to Fig.
2.1 for three independent experiments.
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intestinal epithelial cells. Therefore, we further investigated whether knockdown of
PKCα gene expression-would affect phosphate uptake. In this study, we cultured
intestinal cells as previously described [10,16], and transfected some of the cultures with
siRNA against PKCα. In initial studies, cells were cultured for 72 h as recommended by
the manufacturer. However, it was observed that this resulted in loss of 1,25(OH)2D3stimulated PKC activity. The duration of tissue culture was subsequently reduced to 24 h
after transfection. Under these conditions a significant increase in phosphate uptake was
observed in nontransfected cells incubated with 1,25(OH)2D3. By comparison, cells
transfected with siRNA to PKCα showed a significant decrease in phosphate uptake in
both vehicle controls and hormone treated cells, relative to nontransfected controls (Fig.
2.5A).
Data presented in Fig. 2.5B indicate that a 300 pM 1,25(OH)2D3 treatment
stimulated phosphate uptake in non transfected cells and cells transfected with scrambled
siRNA to a similar extent. No such stimulation was observed in cells transfected with
siRNA against PKCβ. We used Western blot analysis to confirm decreased PKCα and
PKCβ levels in transfected cells relative to nontransfected cells (Figs. 2.6A and 2.6B,
respectively). The results showed a significant decrease in immunoreactivity of PKCα in
transfected cells (TF PKCα) by 74% (P < 0.001) when compared with nontransfected
cells (NTF). Transfection with siRNA against PKCβ produced a 42% knockdown in
expression (P < 0.001).

34

Fig. 2.5 (A) Effect of siRNA against PKCα on phosphate uptake in cultured intestinal
cells. Isolated cells were resuspended in 40 ml of GBSS (Gey’s balanced salt solution)
and 200 µl pipetted into 35 mm plastic Petri dishes containing 3 ml of RPMI-1640
medium and antibiotics (100 units/ml penicillin, 100 mg/ml streptomycin, Sigma). The
cells were incubated for 24 h (in the absence of serum) at 37 °C with 5% CO2/95% air to
promote cell adhesion and then transfected. The transfection protocol is described in
materials and methods. After 24 h, cultured cells were incubated with or without 300 pM
1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of H332PO4 for 7
min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by the addition of
0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells were scraped
and radioactivity determined by liquid scintillation counting. Data are represented as
mean + S.E.M. for nine to eighteen independent experiments (**P < 0.01, ***P < 0.001,
relative to corresponding controls).
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Fig. 2.5 (B) Effect of siRNA against PKCβ on phosphate uptake in cultured intestinal
cells. Isolated cells were resuspended in 40 ml of GBSS (Gey’s balanced salt solution)
and 200 µl pipetted into 35 mm plastic Petri dishes containing 3 ml of RPMI-1640
medium and antibiotics (100 units/ml penicillin, 100 mg/ml streptomycin, Sigma). The
cells were incubated for 24 h (in the absence of serum) at 37 °C with 5% CO2/95% air to
promote cell adhesion and then transfected. The transfection protocol is described in
materials and methods. After 24 h, cultured cells were incubated with or without 300 pM
1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of H332PO4 for 7
min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by the addition of
0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells were scraped
and radioactivity determined by liquid scintillation counting. Data are represented as
mean + S.E.M. for nine to eighteen independent experiments (**P < 0.01, ***P < 0.001,
relative to corresponding controls).
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Fig. 2.6 Western analysis with anti-PKCα or PKCβ in nontransfected cells and cells
transfected with siRNA. Intestinal cells were cultured as described in the legend to Fig.
2.5. Westerns were run (A) using anti-PKCα and as a primary antibody or (B) anti PKCβ
as primary antibody. Lanes 1 and 2 were nontransfected cells, lane 3 and 4 were
transfected cells.

Effect of PKCα blocker (safingol) PKC β blocker
([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl-)
4-anilino-1H-pyrrole-2,5-dione]) on phosphate uptake
in intestinal cell suspensions
The results of PKCα/β blockers confirmed the results from the previous study
that these two PKC isotypes are involved in mediating 1,25(OH)2D3-stimulated
phosphate uptake in intestinal epithelial cells. The result from PKCα blocker
experiments demonstrated a significant decrease in phosphate uptake in cells treated with
300 pM 1,25(OH)2D3 plus safingol at 3, 7 and 10 min (0.987 + 0.032dd, 0.812 + 0.071dd,

37
0.853 + 0.055dd, respectively, ddP value < 0.01) when compared with cells treated with
1,25(OH)2D3 at the same time point (1.374 + 0.109, 1.280 + 0.080, 1.227 + 0.081) (Fig
2.7A). Whereas the results from PKCβ blocker experiments showed a statistically
significant decrease in phosphate uptake in intestinal cells treated with 300 pM
1,25(OH)2D3 plus PKCβ blocker at 1, 3, 5, 7 and 10 min (1.056 + 0.025dd, 0.930 +
0.148dd, 0.980 + 0.073ddd, 0.988 + 0.067dd, 0.997 + 0.049dd, respectively, dd,dddP value <
0.01, 0.001 ) when compared with cells treated with 1,25(OH)2D3 at the same time
points (0.0947 + 0.042, 1.018 + 0.070, 0.903 + 0.140, 0.933 + 0.046, 0.933 + 0.141,
respectively (Fig 2.7B).
Discussion
We have previously reported that phorbol ester—a stimulator of PKC activity—
increases phosphate uptake in chick intestinal cells [7,17], whereas forskolin—an
activator of adenylate cyclase—does not [7]. Protein kinase C isozymes consist of lipid
dependent serine/threonine kinases which include Ca2+ -dependent, Ca2+ -independent or
novel forms. Although PKC isotypes are similar in structure, they differ in subcellular
and tissue distribution, suggesting that they have different functions [11]. In the current
study we have found that the biphasic dose response curve for PKCα redistribution to
subcellular membranes most closely parallels that for 1,25(OH)2D3-mediated phosphate
uptake and transport [7]: increasing stimulation up to an optimal concentration of 300 pM
steroid, followed by inhibition at 650 pM hormone. By comparison, 1,25(OH)2D3stimulated PKCβ activity exhibited activation at both 300- and 650 pM hormone, which
corresponds more closely with stimulated calcium transport [18]. While we have
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Fig. 2.7
A) Effect of the chemical PKCα blocker (safingol) on phosphate uptake in intestinal cell
suspensions. Enterocytes isolated by citrate chelation were resuspended in Gey’s
Balanced Salt Solution (GBSS; 23oC) containing 0.1% BSA and combined with 2 μCi/ml
of H332PO4, final concentration, at the start of the time course studies. Aliquots of cells
were pipetted into four fresh tubes and samples (100 μl) were removed at T = -5 and -1
min to establish basal uptake. At T = 0 min, the cells were treated with the vehicle
ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to produce the following
incubation conditions: (A) (1) controls (open circles) (2) 300 pM 1,25(OH)2D3
(closed circles) (3) controls in the presence of the PKCα blocker (open triangles) (4) 300
pM 1,25(OH)2D3 in the presence of the PKCα blocker (closed triangles) .
(B) Effect of the chemical PKC β blocker ([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)4-anilino-1H-pyrrole-2,5-dione]) on phosphate uptake in intestinal cell suspensions.
Another series of experiments were done with the same procedure to produce the
following conditions: (1) controls (open circle) (2) 300 pM 1,25(OH)2D3 (closed circles)
(3) controls in the presence of the PKCβ blocker (open triangles) (4) 300 pM
1,25(OH)2D3 in the presence of the PKCβ blocker (closed triangles). At T = 1, 3, 5, 7,
and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS. Cell samples
were centrifuged (1,000 x g, 5 min, 4oC), supernatants decanted and pellets analyzed for
radioactivity and protein. Specific radioactivity (cpm/μg protein) was calculated and then
values obtained for the treated phase were normalized to average basal phase. (aa,cc,dd P <
0.01, relative to controls, controls plus PKCα/β blockers and 1,25(OH)2D3 plus PKCα/β
blockers, respectively). Data are presented as mean treated/average basal ratios + SEM.
(aaa,ccc,ddd P < 0.001, relative to controls, controls plus PKCα/β blockers and 1,25(OH)2D3

identified the PKA signaling pathway as the likely mediator of calcium uptake in
intestinal cells [19,20], PKC signaling has been identified in calcium extrusion [21].
Similarly, the study of Farhadi et al. [22] indicated that PKC normalized intracellular
calcium by modulating calcium efflux.
However, we tested the potential role of either isotype in hormone-stimulated
phosphate uptake in experiments with siRNA. Further support for the role of PKCα in
steroid-enhanced phosphate uptake comes from studies with siRNA. Transfection of
intestinal cells with this reagent resulted in both decreased protein levels of the enzyme
and inhibition of 1,25(OH)2D3-mediated increases in 32P uptake. Our finding that
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siRNA transfection of cells that were then treated with vehicle also showed decreased
phosphate uptake relative to non transfected vehicle controls, suggests that PKCα activity
also contributes to basal efflux. Equivalent experiments with siRNA against PKCβ
further support a role of this isotype in 1,25(OH)2D3–stimulated phosphate uptake as
well.
Additional experiments were performed to examine the role of PKCα and PKCβ
in 1,25(OH)2D3-mediated phosphate uptake in cell suspension studies. The results
confirmed our previous siRNA studies and indicate that both PKCα and PKCβ are
involved in the signal transduction mechanism of steroid-mediated phosphate uptake in
intestinal cells.
In duodenum of young rats by comparison, Balogh et al. [9] found 1,25(OH)2D3induced redistribution of PKC α, β, and δ to various compartments including nucleus and
cellular membranes. Using rat colonocytes, Wali et al. [12] found steroid-enhanced
activation of PKC α, and βII in brush border membranes relative to basal lateral
membranes. Thus, this signal transduction pathway is clearly central to the rapid actions
of 1,25(OH)2D3 in intestine. Differences in relative contributions of any given isotype
are most likely due to species differences.
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CHAPTER 3
PROTEIN KINASE C ISOTYPES IN SIGNAL TRANSDUCTION FOR THE 1,25D3MARRS RECEPTOR (ERp57/PDIA3) IN STEROID HORMONE-STIMULATED
CALCIUM EXTRUSION2

Abstract
Protein kinase C (PKC) is involved in the rapid 1,25(OH)2D3-mediated extrusion
of calcium in chick intestinal epithelial cells. The previous report demonstrated that
PKCα and PKCβ redistribution corresponded to the dose-response curve for calcium
extrusion. We verified the role of both PKCα and PKCβ in hormone-stimulated calcium
extrusion by using chemical inhibitors of PKCα (safingol) and PKCβ ([3-(1-(3-Imidazol1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione]) in intestinal cell
suspensions. The results demonstrated that blocking PKCβ activity inhibited the
extrusion of calcium (resulting in increased calcium uptake) from intestinal cells treated
with 1,25(OH)2D3 when compared with vehicle controls (P < 0.001). While the PKCα
blocker did not show any difference in calcium extrusion among the treatment groups.
Similar results were also found in further experiments with transfection of siRNA to
PKCα or PKCβ in primary intestinal cell culture. The results also indicated that there
was no change in calcium extrusion in cells transfected with siRNA to PKCα, whereas
the siRNA to PKCβ significantly decreased calcium extrusion in 1,25(OH)2D3-treated
cells when compared with the corresponding hormone-treated cells in transfected and
nontransfected cells (P < 0.01). Using confocal microscopy, we reduced the hormone
2
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exposure to 30 sec in order to view redistribution of PKCα and PKCβ. Rapid
redistribution of anti-PKCα immunoreactivity was found to significantly increase
fluorescence in the apical membrane region after a 30 sec exposure of cells to 300- or 650
pM 1,25(OH)2D3 (P < 0.01 and 0.001, respectively). By comparison, anti-PKCβ
immunofluorescence was found to increase significantly in the basal lateral region of the
cells, relative to controls after the exposure of cells to 300- (P < 0.01) or 650 pM (P <
0.05) seco-steroid. The results suggest that PKCβ is the PKC isotype involved in
1,25(OH)2D3-mediated calcium efflux in intestinal epithelial cells.
Introduction
Calcium, the most abundant mineral in the body is an essential ion. It plays an
important role in a variety of physiological functions including structural (skeleton and
teeth) and signaling functions (muscle contraction, nerve impulse conduction, hormone
and enzyme secretion, and as a secondary messenger in several pathways). Therefore, the
control of calcium concentrations in the blood and extracellular fluid is necessary to
maintain the normal functions of cells as well as the prevention of calcium accumulation
in the cells (Wasserman and Fullmer, 1995; Forsell et al., 2006). Normally, the input and
output of calcium is adjusted to the physiological needs of the body. Either in normal or
disturbed calcium homeostasis, cells will have the way to control events to protect them
from cytotoxicity (Khanal and Nemere, 2008). 1,25(OH)2D3 is one of the active
metabolites if vitamin D and has been reported to maintain calcium homeostasis (Khanal
and Nemere, 2008; Bronner, 2009; Oudshoorn et al., 2009) and it has been suggested that
PKC signal transduction is involved and mediated through the 1,25D3-MARRS receptor
(Nemere, 2005).

46
A previous report demonstrated that PKC signaling has been identified in
calcium extrusion (Nemere and Campbell, 2000; Khanal et al, 2008) possibly by
facilitating exocytosis of vesicular transport calcium (Sterling and Nemere, 2005),
whereas the PKA signaling pathway is the likely mediator of calcium uptake in intestinal
cells (Phadnis and Nemere, 2003; Sterling and Nemere, 2007; Khanal et al., 2008).
Studies in rat duodenum (Balogh et al., 2000) have shown that 1,25(OH)2D3 can activate
subcellular distribution of specific PKC isozymes, and hormone regulated enzyme
modulation and redistribution were impaired with aging. In addition, Dranitzki-Elhalel et
al. (1999) suggested that the action of 1,25(OH)2D3 on calcium flux from cultured bone is
mediated, in part, via activation of PKC. The study of Farhadi et al. (2006) indicated that
PKC normalized intracellular calcium by modulating calcium efflux. Korchak et al.
(2001) demonstrated that PKC is the regulator at several points in Ca2+ mobilization in
neutrophils and HL60 cells. In addition, the Ca2+ dependent PKCs are known to regulate
the activity of several membrane bound ion channels and carriers in various tissues,
thereby modulating transmembrane ion transport (Halet et al., 2004), bicarbonate
transport in rat jejunum (Orsenigo et al., 2002), and Ca2+ pump and Ca2+ channel activity
in sickle cells (Fathallah et al., 1997).
In small intestine, various PKC isoforms have been identified at the mRNA or
protein level, including classical PKCs (cPKCs; Farhadi et al., 2006). Different isotypes
elicit the differences in tissue expression, subcellular distribution, cofactor requirements
and substrate specificity (Jiang et al., 1995), and then lead each PKC to have a specific
function in the signal transduction mechanism. However, how certain PKC isotypes
influence the activation of calcium transport (Balogh et al., 1997; Larsson and Nemere,
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2003) in the small intestine remains unknown. The purpose of this study was to
determine which Ca2+ dependent PKCs regulate the calcium efflux system, in order to
provide a more knowledgeable cellular and molecular mechanism of 1,25(OH)2D3stimulated calcium extrusion.
Materials and Methods
Animal and Surgical Methods
All protocols were approved by the Institutional Animal Care and Use Committee
at Utah State University (Logan, UT). White leghorn cockerels (Privett Hatchery;
Portales, NM) were obtained on the day of hatch and raised for 3-7 wks on a vitamin Dreplete diet (Nutrena Feeds; Murray, UT). On the day of the experiments, chicks were
anesthetized with chloropent (0.3 ml/100 g body weight), the duodenal loop was removed
to ice-cold 0.9% saline and chilled for 15 min. The pancreas was excised and the
duodenal loop was everted and rinsed three times with ice-cold saline.
Cell Isolation
Intestinal epithelial cells were isolated as previously described (Nemere at al.,
2004; Sterling and Nemere, 2005). The everted duodenal loop was gently stirred for 15
min at 23oC

in citrate chelation solution containing 96 mM NaCl, 27 mM

NaCitrate.2H2O, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM Na2HPO4, pH 5.0. The intestinal
segment was then transferred to fresh solution and cells released in the previous
incubation transferred to 50-ml conical centrifuge tubes. The isolation protocol was
repeated two more times. The cells were collected by low speed centrifugation (500 x g,
5 min, 4oC). Cell pellets were resuspended in Gey’s Balanced Salt Solution (GBSS, 119
mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM NaHPO4, 1.03 mM MgCl2.6H2O,
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0.28 mM MgSO4.7H2O, 0.9 mM CaCl2, pH 7.4). To minimize clumping, the cells were
gently spread along the walls of the centrifuge tube with a Teflon rod, and roomtemperature GBSS added drop-wise, with stirring, until a suspension was formed.
Cell suspensions and calcium uptake
Chicken intestinal cells were isolated by citrate chelation as described above and
resuspended in room temperature GBSS (23oC) containing 0.1% BSA. Fourteen
milliliters of cell suspension were pipetted into polypropylene tubes which contained 1
μCi/ml of 45CaCl2, final concentration (Perkin Elmer Life Sciences, Boston, MA), at T =
-10 min. Aliquots (3.2 ml) of cell suspensions were pipetted into four fresh tubes and
samples (100 μl) removed at T = -5 and -1 min to establish basal uptake. At T = 0 min,
the cells were treated with the vehicle ethanol (final concentration < 0.05%) or 300 pM
1,25(OH)2D3 to produce the following incubation conditions: (1) controls (2) 300 pM
1,25(OH)2D3 (3) control plus PKCα blocker (safingol; EMD Chemicals, Gibbstown, NJ)
(4) 300 pM 1,25(OH)2D3 plus PKCα blocker. Another series of experiments were done
with the same procedure to produce the following conditions: (1) controls (2) 300 pM
1,25(OH)2D3 (3) controls plus PKCβ blocker [(3-(1-(3-imidazol-1-ylpropyl)-1H-indol-3yl)-4-anilino-1H-pyrrole-2,5-dione; EMD Chemicals, Gibbstown, NJ] (4) 300 pM
1,25(OH)2D3 plus PKCβ blocker. At T = 1, 3, 5, 7, and 10 min, 100 μl samples were
pipetted into 900 μl of ice-cold GBSS to stop uptake. Cell samples were placed on ice
and centrifuged (1,000 x g, 5 min, 4oC) at the end of the time course. The supernatants
were decanted and the tubes swabbed with a Kimwipe while still in the inverted position.
The pellets were resuspended in 500 μl of double-distilled water. The aliquots (100 μl)
were pipetted into 3 ml of liquid scintillation cocktail for the determination of
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radioactivity and 20 µl of aliquots taken to determine protein using the Bradford reagent.
Specific radioactivity (cpm/μg protein) was calculated and then values obtained for the
treated phase normalized to average basal phase.
Cell Culture
For studies with siRNA against PKCα or PKCβ (Dharmacon, Inc., Lafayette,
CO), cells were resuspended in 40 ml of GBSS and aliquots (0.2 ml) pipetted into 35 mm
plastic Petri dishes (Falcon, Fisher Scientific; Franklin Lakes, NJ) with 3 ml of RPMI1640 medium (Hyclone, Logan, UT), and antibiotics containing 100 units/ml of penicillin
and 100 µg/ml of streptomycin (Sigma Chemical Co; St. Louis, MO). The cells were
incubated overnight at 37oC, 5% CO2/95% air without serum to promote cell adherence.
The following day, medium was aspirated and the cells were transfected with SiImporter
(Millipore, Bedford, MA) as described by the manufacturer’s product protocol (Upstate,
Lake Placid, NY, 2005) with 100 nM siRNA, final concentration (Dharmacon, inc.,
Lafayette, CO). Briefly, for each plate 930 µl of RPMI-1640 medium was combined with
65 µl of a solution containing 5 µl of SiImporter, 25 µl of siRNA diluent, 35 µl of RPMI1640 and 5 µl of siRNA (transfected cells) or scrambled RNA (Santa Cruz
Biotechnology, Santa Cruz, CA) or without siRNA (mock transfected cells), mixed
gently and incubated at room temperature for 5 min. The transfection mixture was then
added to the cultured cells and incubated for 4 h After the incubation period, 3 ml of
RPMI-1640 with 10% FBS and antibiotics were added to each Petri dishes (Falcon
Scientific Products; Franklin Lakes, NJ). Incubation was continued for 24 h at 37oC, 5%
CO2/95% air and the cultures were assayed for calcium uptake as described below.
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Calcium Uptake
After 48 h of incubation, the medium was aspirated and replaced with 1 ml of
GBSS containing 0.1% BSA (23oC). At T = 0, an equal volume of buffer was added
containing radioactivity (1 µCi of 45CaCl2 [Perkin Elmer Life Sciences, Boston, MA] per
ml, final concentration) and either vehicle (0.012% ethanol, final concentration) or 300
pM 1,25(OH)2D3 (final concentration), and the incubation continued for 7 min—a time
found earlier to be optimal for observing hormone-mediated differences in uptake (Peery
and Nemere, 2007). Media were then aspirated and the cells were rinsed with 4 ml of icecold GBSS three times, followed by the addition of 0.5 ml of lysis buffer (0.1% (v/v)
triton X-100 in TED containing 10 mM Tris, 1.25 mM EDTA, 2mM dithiothreitol, pH
7.4). Cells were scraped, solubilized, and collected for determination of radioactivity by
liquid scintillation spectrophotometry and protein.
Confocal Microscopy
Intestinal cells were isolated by citrate chelation and resuspended in 40 ml of GBSS.
A coverslip was placed in the bottom of each Petri dish and 3 ml of RPMI 1640 and 0.5
ml of cell suspension added. The cells were cultured overnight. The following morning,
media were replaced with 1 ml of GBSS containing 0.1% BSA. At T = 0 min, either
vehicle (0.001% ethanol, final concentration), 130-, 300-, or 650 pM 1,25(OH)2D3 were
added. At T = 30 sec, media were replaced with 1 ml of 3% paraformaldehyde, 3%
sucrose in PBS and the cells were fixed for 20 min. After washing three times with PBS,
cells were permeabilized for 5 min with 0.1% Triton X-100 in PBS, washed three times
with PBS, and incubated with primary antibody (rabbit anti-PKCα or mouse anti-PKCβ,
1/500 dilution with PBS-0.1% BSA; both from Zymed, San Francisco, CA) for 30 min,
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followed by three washes with PBS. Cells were then incubated with fluoresceinconjugated secondary antibody (Jackson Immunoresearch, West Grove, PA) for 30 min,
washed three times and mounted on 10% 1 M Tris in 80% glycerol on a microscope
slide. Coverslips were blotted, and sealed with nail polish. Prepared samples were
analyzed using a BioRad MRC 1024 laser-scanning confocal microscope system
mounted in the Keller position and attached to a Nikon TE-200 microscope. Images were
captured with BioRad LASERSHARP acquisition software, using a 40x objective lens
(Sterling and Nemere, 2007). The images were analyzed for pixel intensity using Adobe
Photoshop 6.0 (Adobe Systems, Inc., San Jose, CA). Briefly, the intensities of intestinal
cells were divided into four parts as follows; BBM, Apical part (two third of the intestinal
cells), BBM and apical part, and BLM (one third of the intestinal cells). The diagram of
intestinal epithelial cells were shown in Fig 3.1.
Brush border membrane (BBM)
Apical region

Basal region
Basolateral membrane (BLM)

Fig. 3.1 Diagram of different regions of intestinal epithelial cells
Protein Determination
The protein concentration was determined using Bradford reagent (BioRad) and
bovine γ-globulin as the protein standard.
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Statistical Analysis
All values were expressed as mean + SEM. Statistical comparisons between two
treatment groups were compared by one way ANOVA (SigmaStat 3.1 and SigmaPlot
9.0). Significant differences were considered to occur at P < 0.05.
Results
Effect of PKCα blocker (safingol) on
1,25(OH)2D3-mediated calcium extrusion
To determine whether PKCα mediates calcium extrusion, freshly isolated
intestinal cells were treated with vehicle or 300 pM 1,25(OH)2D3. in the absence or
presence of inhibitor, and aliquots removed at the indicated times. The results from
experiments using the chemical PKCα blocker demonstrated no difference in calcium
extrusion (lack of altered calcium uptake) in vehicle controls, 1,25(OH)2D3 treated,
vehicle control plus PKCα blocker or 1,25(OH)2D3 plus PKCα blocker groups (Fig 3.2).
Therefore, it is likely that PKCα is not the PKC isotype involved in steroid hormonestimulated calcium efflux from intestinal epithelial cells.
Effect of PKCβ blocker [(3-(1-(3-imidazol-1-ylpropyl)1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione] on
1,25(OH)2D3-mediated calcium extrusion
The equivalent experiments were undertaken to study the involvement of
PKCβ on calcium efflux. The effect of the chemical PKCβ inhibitor was to cause a
significant decrease in calcium extrusion (increase in calcium uptake) in cells treated with
300 pM 1,25(OH)2D3 plus PKCβ blocker at 3, 5, 7 and 10 min (1.311 + 0.086bb, 1.396 +
0.168bbb, 1.454 + 0.160bb and 1.400 + 0.067bb, respectively, bb,bbbP < 0.01, 0.001) when
compared with 1,25(OH)2D3 at the corresponding time points (1.025 + 0.062, 0.993 +
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Fig. 3.2 Effect of the chemical PKCα blocker (safingol) on calcium uptake in intestinal
cell suspensions. Enterocytes isolated by citrate chelation were resuspended in Gey’s
Balanced Salt Solution (GBSS; 23oC) containing 0.1% BSA and combined with 2 μCi/ml
of H332PO4, final concentration, at the start of the time course studies. Aliquots of cells
were pipetted into four fresh tubes and samples (100 μl) were removed at T = -5 and -1
min to establish basal uptake. At T = 0 min, the cells were treated with the vehicle
ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to produce the following
incubation conditions: (1) controls (open circles) (2) 300 pM 1,25(OH)2D3 (closed
circles) (3) controls in the presence of the PKCα blocker (open triangles) (4) 300 pM
1,25(OH)2D3 in the presence of the PKCα blocker (closed triangles). Data are presented
as mean treated/average basal ratios + SEM.

0.087, 1.001 + 0.094 and 0.963 + 0.096, respectively; Fig 3.3). The percentage decrease
in calcium efflux was approximately 29 (3 min), 40 (5 min), 45 (7 min) and 44% (10
min) when compared to cells treated with PKCβ blocker plus 1,25(OH)2D3 and cells
treated with hormone alone.
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Fig. 3.3 Effect of the chemical PKC β blocker ([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol3-yl)-4-anilino-1H-pyrrole-2,5-dione]) on calcium uptake in intestinal cells suspension.
Another series of experiments were done with the same procedure as described in Fig. 3.2
to produce the following conditions: (1) controls (open circle) (2) 300 pM 1,25(OH)2D3
(closed circles) (3) controls in the presence of the PKCβ blocker (open triangles) (4) 300
pM 1,25(OH)2D3 in the presence of the PKCβ blocker (closed triangles). At T = 1, 3, 5,
7, and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS. Cell samples
were centrifuged (1,000 x g, 5 min, 4oC), supernatants decanted and pellets analyzed for
radioactivity and protein. Specific radioactivity (cpm/μg protein) was calculated and then
values obtained for the treated phase were normalized to average basal phase. Data are
presented as mean treated/average basal ratios + SEM. (aa,bb,cc P < 0.01 and aaa,bbb,ddd P <
0.001, relative to controls, 1,25(OH)2D3 and controls plus PKCβ blockers, respectively).

Effect of siRNA against PKCα on calcium
extrusion in cultured intestinal cells
The results of the previous studies suggested that PKCβ is the isotype most likely
mediating 1,25(OH)2D3-stimulated calcium extrusion in intestinal epithelial cells. We
first further investigated the effect of knockdown of PKCα gene expression on calcium
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efflux. In this study, we cultured intestinal cells as previously described (Nemere et al.,
2004; Sterling and Nemere, 2005), and transfected primary intestinal cell cultures with
siRNA against PKCα. Cells were treated with vehicle control or 300 pM steroid
hormone. The result was that no difference was observed between nontransfected and
transfected cells (Fig 3.4).
Effect of siRNA against PKCβ on calcium
extrusion in cultured intestinal cells.
Under the same conditions as the previous experiments, siRNA against PKCβ
resulted in a significant increase in calcium uptake in hormone treated (169.39 + 3.55aaa
cpm/μg protein, P < 0.001), relative to nontransfected controls and hormone treated
(82.66 + 2.06, 144.05 + 4.03 cpm/μg protein, respectively) and mock transfected cells
(79.59 + 2.30 cpm/μg protein). No difference was found in nontransfected cells and cells
transfected with scrambled siRNA (Fig 3.5). Western blots with anti-PKCα and antiPKCβ verified the protein expression was decreased approximately by 40% (data not
shown).
Effect of 1,25(OH)2D3 on anti-PKCα immunofluorescence
distribution as judged by confocal microscopy
We used confocal microscopy to determine the involvement of PKCα in steroid
hormone-mediated signal transduction. Intestinal cells were cultured on cover slips,
treated with vehicle or 130-, 300-, or 650 pM 1,25(OH)2D3 for 30 sec in order to
assessthe redistribution of PKCα. Cultured cells were incubated with anti-PKCα and the
brushborder membranes were stained with rhodamine-conjugated phalloidin. Non
specific staining controls were negative (data not shown). Fig 3.6A demonstrates the
distribution of fluorescein conjugated secondary antibody to anti- PKCα which was
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Fig. 3.4 Effect of siRNA to PKCα on calcium uptake in cultured intestinal cells. Isolated
cells were resuspended in 40 ml of GBSS and 200 µl pipetted into 35 mm plastic Petri
dishes containing 3 ml of RPMI-1640 medium and antibiotics (100 units/ml penicillin,
100 mg/ml streptomycin, Sigma). The cells were incubated for 24 h (in the absence of
serum) at 37 °C with 5% CO2/95% air and then transfected. The transfection protocol is
described in materials and methods. After 24 h cultured cells were incubated with or
without 300 pM 1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of
H332PO4 for 7 min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by
the addition of 0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells
were scraped and radioactivity determined by liquid scintillation counting. Data are
represented as mean + S.E.M. (***P < 0.001, relative to corresponding controls).

found to be greater in the apical part of intestinal cells treated with 300- and 650 pM (P <
0.01, 0.001, respectively) than in controls or in the 130 pM treatment group. The graph
shown in Fig 3.6B depicts the results of confocal microscopy as pixel intensity with the
data were corrected for non specific controls. The percentage increase in pixel intensity
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Fig. 3.5 Effect of siRNA to PKCβ on calcium uptake in cultured intestinal cells. Cells
were cultured and treated as described in Fig. 3.3. Data are represented as mean + S.E.M.
(aa, ***P < 0.01, 0.001, relative to corresponding hormone-treated and vehicle controls,
respectively).

was 21 % and 25% in the apical region of the cells and 15% and 26% in brush border
plus apical area in 300- and 650 pM steroid-treated cells, respectively, when compared
with the vehicle controls. There were no differences in pixel intensity in brush borders or
basal lateral membranes alone. This result showed that there was rapid redistribution of
PKCα when the cells were treated with hormone.
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Fig. 3.6A Immunocytochemical localization of PKCα in isolated intestinal cells.
Intestinal cells were isolated by citrate chelation as described in materials and methods.
The cells were cultured overnight. The following morning, media were aspirated and
replaced with 1 ml of GBSS containing 0.1% BSA. At T = 0 min, either vehicle (0.001%
ethanol, final concentration), 130-, 300-, or 650 pM 1,25(OH)2D3 were added. At T = 30
sec, media were aspirated and replaced with 1 ml of 3% paraformaldehyde, 3% sucrose in
PBS, and the cells were fixed. After washing three times with PBS, cells were
permeabilized for 5 min with 0.1% Triton X-100 in PBS, washed three times with PBS,
and incubated with primary antibody (rabbit anti PKCα, 1/500 dilution) with PBS-0.1%
BSA for 30 min, followed by three washes with PBS. Cells were then incubated with
fluorescein-conjugated secondary antibody for 30 min, washed three times and mounted
on 10% 1 M TRIS in 80% glycerol on microscope slide. Coverslip were blotted, and
sealed with nail polish.

Effect of 1,25(OH)2D3 on anti-PKCβ immunofluorescence
distribution as judged by confocal microscopy
Fig 3.7A shows the distribution of fluorescein-conjugated secondary antibody to
anti- PKCβ. In contrast to the distribution of anti-PKCα, the anti-PKCβ fluorescein was
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Fig. 3.6B Quantitative analysis of the distribution of fluorescence intensity. The graph
presents the mean pixel intensity of fluorescein-conjugated secondary antibody against
anti-PKCα in different cellular regions. Data represent mean + SEM (**, *** P < 0.01,
0.001 when compared with the corresponding controls).

found to be greater in the basal lateral region of intestinal cells treated with 300- or 650
pM (P < 0.01, 0.05, respectively) when compared with controls and the 130 pM treatment
group.
Figure 3.7B presents these results in graphic form in which pixel intensity is
corrected for non specific staining controls. The percentage increase in pixel intensity
was 18% and 13% in the basal lateral region of cells treated with 300- and 650 pM,
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Fig. 3.7A Immunocytochemical localization of PKCβ in isolated intestinal cells. Cells
were prepared and treated as described in Fig. 3.5 (A), except the cells were incubated
with mouse anti-PKCβ, 1/500 dilution as the primary antibody.

respectively, when compared with vehicle controls. There were no differences in pixel
intensity in other cellular regions. These results demonstrate that PKCβ was redistributed
after incubating cells with 1,25(OH)2D3.
Discussion
Using Forskolin, a PKA activator, we have reported elsewhere that the PKA
signaling pathway is the mediator of calcium uptake in intestinal cells (Phadnis and
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Fig 3.7B Quantitative analysis of the distribution of fluorescence intensity. The graph
presents the mean pixel intensity of fluorescein-conjugated secondary antibody to antiPKCβ at different cellular regions. Data are presented as mean + SEM (*,** P < 0.05,
0.01 when compared with corresponding controls).

Nemere, 2003; Sterling and Nemere, 2007; Khanal et al., 2008), whereas the study by
Nemere and Campbell (2000) has identified that PKC signaling is involved in calcium
extrusion. A recent study (Khanal et al., 2008) has reported that phorbol ester, a PKC
activator, stimulated Ca2+ efflux, and forskolin stimulated uptake. Furthermore, our
previous study (see Chapter 2) showed the dose response curve of 1,25(OH)2D3stimulated PKCβ activity exhibited activation at both 300- and 650 pM hormone, which
corresponds with the curve for activated calcium transport (Nemere et al., 1984).
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In the current study, we used chemical blockers for PKCα and PKCβ and found
that use of the PKCβ blocker resulted in stimulated calcium uptake in intestinal cells
treated with 1,25(OH)2D3. This result indicates that the increase in calcium uptake,
resulting from an inhibition of calcium efflux from the cells was due to the 1,25(OH)2D3
mediated PKCβ signal transduction pathway. While equivalent experiments were
performed to identify the involvement of PKCα, the results showed there was no
difference in calcium uptake in cells treated with the PKCα blocker plus steroid hormone
when compared to the vehicle control and hormone treated cells alone. From this result, it
is likely to conclude that PKCα in not involved in 1,25(OH)2D3-mediated calcium
extrusion.
Correspondingly, the experiment with siRNA against PKCβ in primary intestinal
cell cultures showed an increase in calcium uptake (in turn, decreased calcium extrusion)
of 25% when compared with cells treated with 1,25(OH)2D3. This result is lower than
with the chemical inhibitor and can be explained by the loss of PKC activity after 72 h of
incubation in cell culture (Khanal et al., 2008). In comparison, siRNA against PKCα
demonstrated no difference in calcium uptake in all treatment groups of both transfected
and nontransfected cells. From the chemical blockers and transfection studies, our
findings clearly indicate that PKCβ is the PKC isotype that mediates the 1,25D3-MARRS
receptor-stimulated calcium extrusion in intestinal epithelial cells whereas PKCα and
PKCβ are involved in steroid-enhanced phosphate uptake (see Chapter 2).
Our study was similar to the study of Farhadi et al. (2006) in Caco-2 cells, where
they reported that PKCβ protects the intestinal cell from oxidant-induced injury through
PKC normalized intracellular calcium by modulating calcium efflux. By contrast,

63
Fathallah et al. (1997) have studied the effect of PKC in deoxygenated sickle cells and
suggested that PKCα stimulated Ca2+ efflux by mediating the phosphorylation of a Ca2+
pump or an associated protein. In addition, Korchak et al. (2001) has report that PKCβ
regulates ligand-initiated Ca2+ uptake in differentiated HL60 cells.
By using confocal microscopy, we have identified the translocation of PKCβ to
the basal lateral region of intestinal cells whereas PKCα translocated to the apical part in
cells treated with different concentration of steroid hormone within 30 sec. The
difference in PKC translocation might be because these two PKC isotypes function
differently in 1,25(OH)2D3-mediated ion transport since individual isotypes have distinct
and specialized functions in cell signaling (Jiang et al., 1995). However, a similar result
has been reported. Sitrin et al. (1999), demonstrated that 1,25(OH)2D3 rapidly stimulates
the translocation of PKCβ, to the basolateral membrane, not the brush border membrane.
However, they found that PKCα, did not translocate to either antipodal plasma
membrane. Balogh et al. (2000) also demonstrated that 1,25(OH)2D3 affects the
subcellular distribution of PKCα, β and δ and these effects are impaired with aging.
These results might be different because of the tissue specificity and species; we have
studied chick intestinal epithelial cells whereas they studied rat colonic cells.
However, the exact mechanism involved in 1,25(OH)2D3 mediated calcium
extrusion is still unknown. It might be that PKC stimulated vesicular transport of calcium
(Sterling and Nemere, 2005) in either a receptor mediated or non receptor mediated
pathway (Le et al., 2002; Le Roy and Wrana, 2005; Alvi et al., 2007). Alternatively,
1,25(OH)2D3 has been reported to upregulate plasma membrane Ca2+-ATPase expression
(Kip and Strehler, 2004) and studies of PKC in many cell types have shown increased
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activity of Ca2+-ATPase and that it is activated by PKC (Kanashiro and Khalil, 1998). In
conclusion, we suggest that PKCβ mediates signal transduction for the 1,25D3-MARRS
receptor (ERp57/PDIA3) in steroid hormone-stimulated calcium extrusion in chick
intestinal epithelial cells, either by the regulation of exocytosis through the basal lateral
membrane and/or by activation of Ca2+-ATPase on the basal lateral membrane of chick
enterocytes.
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CHAPTER 4
SUMMARY AND CONCLUSION
Summary
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the steroid hormone that regulates
phosphate and calcium homeostasis. The effects of this secosteroid hormone on its target
organs are mediated in part by classical mechanisms via a nuclear vitamin D receptor
(nVDR). This slow action modulates gene transcription to generate genomic responses in
cells (Christakos et al., 2003; Norman et al., 2004). In addition to this slow response
mechanism, 1,25(OH)2D3 also a rapid action through the 1,25D3-MARRS receptor to
generate pregenomic actions such as modulation of ion transport, membrane fluidity and
generation of signal transduction inside cells (Nemere et al., 1994; de Boland and
Norman, 1998; Nemere et al., 1998; Fleet, 2004).
From the previous studies in chick intestinal epithelial cells and
immunohistochemistry, we found that 1,25(OH)2D3-mediated rapid uptake of phosphate
(Zhao and Nemere, 2002; Peery and Nemere, 2007) and extrusion of calcium (Nemere
and Campbell, 2000) is mediated by a PKC signal transduction mechanism.
The mechanism of signal transduction by PKC begins with the binding of receptor
to ligands such as hormones and growth factors to activate phospholipase C. The
phospholipase C hydrolyses phosphatidylinositol 4,5 bisphosphate (PIP2) and produces
two secondary messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG).
The latter molecule can then activate PKC (Kanashiro and Khalil, 1998). There are
several isotypes of PKC that are different in their structure, function and tissue
expression. In this study, I focused on the classical PKC which includes PKCα, β and γ.
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The first series of experiments were performed to determine which isotype(s) of
protein kinase C (PKC) is/are activated by the 1,25D3-MARRS receptor (ERp57/PDIA3)
which has been reported to be a plasma membrane receptor for 1,25(OH)2D3 (Nemere et
al., 2004) in hormone stimulated phosphate uptake. The present work demonstrated that
1,25(OH)2D3 rapidly stimulated phosphate uptake within 1 min with the highest
immunoreactivity in the P2 fractions of cells treated with 300 pM 1,25(OH)2D3 in
western blots with anti-PKCα and 300 pM- and 650 pM-steroid hormone for anti-PKCβ.
Therefore, we used these two PKC isotypes for the next experiments. The studies with
siRNA to PKCα and PKCβ and chemical inhibitors of PKCα (safingol) and PKCβ ([3(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione])
demonstrated the involvement of these two isotypes in 1,25(OH)2D3-mediated phosphate
uptake in chick intestinal epithelial cells. Therefore, it is likely to be that PKCα and
PKCβ are the PKC isotypes that regulate phosphate homeostasis in the small intestine.
Our finding is similar to the study in rat duodenum (Balogh et al., 2000) and colon (Wali
et al., 1998, Sitrin et al., 1999). These workers found that 1,25(OH)2D3-enhanced the
redistribution of PKC α, β, and δ to the basal lateral membrane. Therefore, the PKC
signal transduction pathway is likely to mediate the rapid pregenomic actions of
1,25(OH)2D3 in intestine. In addition, 1,25(OH)2D3 was also found to activate the MAP
kinase pathway in chick enterocytes (de Boland and Norman, 1998). The mechanism of
steroid stimulated phosphate uptake may possibly be through the exocytosis of NaPi
cotransporters which are found at the brush border membrane of intestinal cells (Biber et
al., 2009). These transporters are involved in the uptake of phosphate across the
membrane. In parathyroid hormone (PTH) stimulation of kidney cells, PKC is suggested
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to phosphorylate a stabilizing protein of the NaPi contransporter that weakens the affinity
to activate the delivery of the transporter to the endocytic machinery (Gisler et al., 2001;
Weinman et al., 2007). Furthermore, signal transduction by PKC might involve
membrane trafficking and the vesicular transport of endocytic vesicles across epithelial
cells (Sterling and Nemere, 2005).
Further experiments were done to examine the involvement of PKC isotypes in
steroid-activated calcium extrusion. The current work demonstrated that a chemical
inhibitor of PKCβ, but not PKCα, in intestinal cell suspension studies can significantly
inhibit 1,25D(OH)2D3-stimulated calcium efflux from intestinal epithelial cells by 50%.
Similar results were also found in further experiments with transfection of siRNA to
PKCα or PKCβ in intestinal primary cell culture. The results also indicated that there was
no change in calcium extrusion in cells transfected with siRNA to PKCα, whereas the
siRNA to PKCβ significantly decreased calcium extrusion (resulting in increased calcium
uptake) in 1,25(OH)2D3-treated cells when compared with the vehicle controls.
Confocal microscopy experiments were undertaken to assess the redistribution of
PKCα and PKCβ in cells exposed to steroid hormone as early as 30 seconds. PKCα was
found to significantly increase in the apical membrane after a 1 minute exposure of cells
to 300- or 650 pM 1,25(OH)2D3. By comparison, anti-PKCβ immunofluorescence was
found to increase significantly in the basal region of cells, relative to controls, following
exposure of cells to 300 pM secosteroid. The combined results demonstrate that PKCβ is
the PKC isotype that is involved in the control of calcium homeostasis by pumping out
the calcium from the cells to prevent cytotoxicity. Vitamin D3 has been reported to
upregulate Ca2+-ATPase expression and increase transcellular calcium flux from the
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apical to the basolateral side in kidney cells (Kip and Strehler, 2004). The mechanism of
PKC in the signal transduction pathway to regulate the extrusion of calcium might be
from the increase in Ca2+-ATPase phosphorylation and Ca2+ pump activity (Wright et al.,
1993). Fathallah et al (1997) reported the activation of PKCα on Ca2+ pump activity in
sickle cells, the difference in PKC isotypes are from the difference in species and tissue
expression of PKC. Another possible mechanism might be the stimulation of exocytosis
of lysosomal vesicles containing Ca2+ in the vesicular transport model (Nemere et al.,
1994;Larsson and Nemere, 2002; Khanal et al., 2008; Khanal and Nemere, 2008). The
mechanism and the model of PKC signal transduction through 1,25D3-MARRS receptor
are shown in Fig. 4.1, and Fig. 4.2, respectively.
Conclusion
From these recent results, we then can conclude that
1. 1,25(OH)2D3-stimulated rapid phosphate uptake and calcium extrusion occur
within seconds, via a pregenomic pathway
2. PKCα and PKCβ play a role in the signal transduction mechanism of
1,25(OH)2D3-mediated phosphate uptake, possibly via the phosphorylation of Na/Pi
cotransporters and/or the regulation of endocytic vesicular transport of phosphate
3. PKCβ is involved in the mechanism of 1,25(OH)2D3-mediated calcium efflux
in chick intestinal epithelial cells by the regulation of exocytosis through the basal lateral
membrane and/or by activation of Ca2+-ATPase or other calcium transporters on the basal
lateral membrane of chick enterocytes.
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Future Study
1. Evaluation of the role of PKC in mediating phosphate and calcium transport in
aging animals
2. Determination of the possible mechanism involved in PKCα and PKCβ signal
transduction through 1,25D3-MARRS receptor-induced phosphate uptake and calcium
extrusion
Benefit
This study provides the basic knowledge of cellular and molecular mechanism of
1,25(OH)2D3 regulated phosphate and calcium homeostasis. The results from this
research may suggest new ways to develop drugs or therapies to improve phosphate and
calcium uptake. Some of therapies may include the means of direct stimulation of
specific PKC isotype in the intestine. This development will promote bone health and
overcome phosphate and calcium malabsorption in response to bone diseases, aging or
patients with chronic renal failure or hyperparathyroidism. Also, this will provide a better
understanding of how cells can maintain their calcium homeostasis in between the input
(absorption) and the output (extrusion) to protect the cells from toxicity.
Furthermore, this study also has implications in agriculture. The production of
manure high in phosphate in poultry farms is a serious problem since it has had an effect
on ecology. The combined research can be used to benefit crop production and would
help minimize the phosphate levels in manure.
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Fig. 4.1 (A) 1,25(OH)2D3 binds to 1,25D3-MARRS receptor (B) the extracellular signal
induces membrane enzyme which is called phospholipase C (PLC), resulting in the
production of diacylglycerol (DAG) and inositol triphosphate (IP3). Intracellular calcium
(Ca2+) releases from the sarcoplasmic reticulum (SER) (C) DAG and Ca2+ causes
activation and translocation of protein kinase C (PKC) from the cytosolic part to
membrane. (D) PKC directly phosphorylates cellular substrates and leads to the alteration
in cellular responses (E) In this case, PKCα and/or β phosphorylates Ca2+-ATPase and
NaPi cotransporter, resulting in the transport of calcium or phosphate from their absortive
site to the circulation.
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Fig. 4.2 Schematic model of PKCα and PKCβ signal transduction through the 1,25D3MARRS receptor in 1,25(OH)2D3-stimulated phosphate uptake and calcium extrusion.
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Abbreviations
μCi

Microcurie, a unit of radiation

μg

Microgram

μl

Microliter

1,25(OH)2D3

1,25-dihydroxyvitamin D3

1,25D3-MARRS

1,25-dihydroxyvitamin D3 membrane
associated, rapid response steroid-binding
receptors

32

P

Radioisotope for phosphorous

45

Ca

Radioisotope for calcium

Ab593

Antibody 593, used to block 1,25D3MARRS receptor

ANOVA

Analysis of variant

Anti-pan PKC

Antibody detects endogenous levels of
almost all protein kinase C isoforms

aPKC

Atypical protein kinase C

BBM

Brush border membrane (luminal side)

BLM

Basolateral membrane (serosal side)

BSA

Bovine serum albumin

Ca2+-ATPase

Plasma membrane calcium transporter
protein

cPKC

Conventional protein kinase C
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P1 fraction

Pellets contain nuclei, BBM and large cell
debris

P2 fraction

Pellets contain BLM, Golgi, mitochondria,
lysosomes and peroxisomes

CPM

Counts per minute, a measurement of
radioactivity

DAG

Diacylglycerol

ECF substrate

Enhanced luminescence substrate

ERp57

Membrane protein of the endoplasmic
reticulum

IP3

Inositol 1,4,5-triphosphate

MAP kinase

Mitogen-activated protein kinase, a
serine/threonine protein kinase

mM

Millimolar

Min

Minute

nPKC

Novel protein kinase C

Npt2b

Sodium Phosphate cotransporter isoform
type 2b

NTF

Nontransfected cells

PBS

Phosphate buffer saline

PDIA3

Protein disulfide isomerase

PIP2

Phosphotidylinositol 4,5-bisphosphate

PKA

Protein kinase A
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PKC

Protein kinase C

PLC

Phospholipase C

pM

Picomolar

PTH

Parathyroid hormone

P value

Probability to test the hypothesis

SDS-PAGE

Sodium dodecyl sulfate polyacrylamide gel
electrophoresis

Sec

Second

SEM

Standard error of mean

siRNA

Small interfering RNA

T

Time

TF

Transfected cells

TRPV6

Transient receptor potential of the vanilloid
type, type of membrane calcium channel

VDR

Vitamin D receptor
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